About

Dr. Aniruddha Pawar is an experienced Interventional Cardiologist with over 7 years of dedicated cardiology practice. Trained at some of Mumbai’s most reputed institutions like Topiwala National Medical College & BYL Nair Hospital, and Seth G.S. Medical College & KEM Hospital; he combines strong academic pedigree with advanced clinical expertise.

 

He specializes in complex coronary and structural heart interventions and is known for a patient-centric approach that blends precision with compassion.

Education & Training

  • DM (Cardiology) – Seth G.S. Medical College & KEM Hospital, Mumbai (2018)
  • MD (Internal Medicine) – Topiwala National Medical College & BYL Nair Hospital, Mumbai (2015)

Professional Experience

  • Consultant Interventional Cardiologist – Bethany Hospital, Kaushalya Hospital, Shri Mahavir Jain Hospital (since 2020)
  • Assistant Professor, Department of Cardiology – KEM Hospital, Mumbai

Clinical Expertise

  • Coronary Angiography & Angioplasty
  • Management of Acute Coronary Syndromes
  • Pacemaker Implantation & Device Therapies
  • Structural Interventions Including Valve and Congenital Procedures
  • Advanced Echocardiography and Non-invasive Cardiac Imaging

Research & Publications

  • Original Article: Validation of ‘Left Ventricular Early Inflow-Outflow Index’ – Indian Heart Journal, 2018
  •  
  • Case Reports published in European Heart Journal, Interventional Cardiology Journal, IHJ Cardiovascular Case Reports, covering topics such as:
    • SA nodal dysfunction
    • Loeffler’s endocarditis
    • Amyloid cardiomyopathy as initial presentation of multiple myeloma
    • Angina equivalents and rare congenital heart disease presentations
     
  • Poster Presentations:
    • His bundle pacing (Indian Society of Electrocardiology, 2019)
    • Novel quantification of mitral regurgitation (CSI, Kolkata, 2017)
     
  • Textbook Contributions:
    • Exercise Testing – API Textbook of Medicine (11th Ed.)
    • Coronary Intervention in Venous Grafts – Cardio Diabetes Update (2017)
     
  • Research Role: Co-investigator in ODYSSEY EAST Trial (Alirocumab vs. Ezetimibe in high-risk patients with hypercholesterolemia).

Memberships & Fellowships

  • Member, Cardiology Society of India (since 2019)
  • Fellow, Society for Cardiovascular Angiography & Intervention (FSCAI) (2024)